NCEL earnings date and last-quarter result: next report 2026-09-02, P/E -0.40. Updated 2026-07-23.
NewcelX (NCEL) Research Hub
NewcelX (NCEL) trades on NASDAQ, CH in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 2.55 USD (-4.14%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -0.40, market cap 0.00B. This hub links to the full technical, earnings and options research available for NCEL.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, CH |
| Last close | 2.55 USD (-4.14%) |
| 52-week range | 2.35 USD – 4.64 USD |
| Trend regime | Range |
| 14-day RSI | 41.2 (Bearish) |
| Trailing P/E | -0.40 |
| Market cap | 0.00B |
| Dividend yield | 0.00% |
| Next earnings | 2026-09-02 |
Available research for NCEL
Covered Call on NCEL: how it works, illustrative setup around the real 2.55 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on NCEL: how it works, illustrative setup around the real 2.55 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on NCEL: how it works, illustrative setup around the real 2.55 USD price, max profit/loss, breakeven and when to use it. Educational.
NCEL technical analysis: range, last 2.55 USD, RSI 41.2, 52w range 2.35 USD–4.64 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is NCEL in?
NewcelX (NCEL) is classified under Healthcare (Biotechnology), listed on NASDAQ, CH.
Is NCEL in an uptrend or downtrend?
As of 2026-10-26, NCEL is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is NCEL's trailing P/E ratio?
NCEL's trailing P/E is -0.40, with a market cap of 0.00B. See the earnings research page for full valuation detail.
When does NCEL next report earnings?
NCEL is next scheduled to report earnings on 2026-09-02.